Skip to main content
179 results:
81. sphingotec transforms into end-to-end diagnostic solutions provider and exclusively represents Nexus Dx IB10 immunoassay portfolio  
The German diagnostics company sphingotec GmbH (Hennigsdorf, Germany) today announced that through its network of regional and local distribution partners it will exclusively offer the Nexus Dx IB10…  
82. sphingotec’s endothelial function biomarker bio-ADM® predicts need for organ support in general ICU patient population  
Diagnostics company SphingoTec GmbH ("sphingotec", Hennigsdorf, Germany) today announced a publication in Critical Care1 with data on 2,000 ICU patients demonstrating that sphingotec‘s…  
83. sphingotec’s biomarker penKid® predicts septic acute kidney injury at time of admission to emergency department  
Diagnostics company SphingoTec GmbH ("sphingotec", Hennigsdorf Germany) today reported on the publication of novel study results of its proprietary kidney function biomarker penKid® in BMC…  
84. sphingotec’s proprietary biomarker bio-ADM® detects residual congestion in patients with heart failure  
Diagnostics company SphingoTec GmbH (sphingotec) today announced the publication of new study results in the European Journal of Heart Failure demonstrating that its proprietary endothelial function…  
Search results 81 until 90 of 179